Pub Date : 2015-01-26eCollection Date: 2014-05-01DOI: 10.4161/21565562.2014.979623
Liza O'Donnell
Haploid round spermatids undergo a remarkable transformation during spermiogenesis. The nucleus polarizes to one side of the cell as the nucleus condenses and elongates, and the microtubule-based manchette sculpts the nucleus into its species-specific head shape. The assembly of the central component of the sperm flagellum, known as the axoneme, begins early in spermiogenesis, and is followed by the assembly of secondary structures needed for normal flagella. The final remodelling of the mature elongated spermatid occurs during spermiation, when the spermatids line up along the luminal edge, shed their residual cytoplasm and are ultimately released into the lumen. Defects in spermiogenesis and spermiation are manifested as low sperm number, abnormal sperm morphology and poor motility and are commonly observed during reproductive toxicant administration, as well as in genetically modified mouse models of male infertility. This chapter summarizes the major physiological processes and the most commonly observed defects in spermiogenesis and spermiation, to aid in the diagnosis of the potential mechanisms that could be perturbed by experimental manipulation such as reproductive toxicant administration.
{"title":"Mechanisms of spermiogenesis and spermiation and how they are disturbed.","authors":"Liza O'Donnell","doi":"10.4161/21565562.2014.979623","DOIUrl":"https://doi.org/10.4161/21565562.2014.979623","url":null,"abstract":"<p><p>Haploid round spermatids undergo a remarkable transformation during spermiogenesis. The nucleus polarizes to one side of the cell as the nucleus condenses and elongates, and the microtubule-based manchette sculpts the nucleus into its species-specific head shape. The assembly of the central component of the sperm flagellum, known as the axoneme, begins early in spermiogenesis, and is followed by the assembly of secondary structures needed for normal flagella. The final remodelling of the mature elongated spermatid occurs during spermiation, when the spermatids line up along the luminal edge, shed their residual cytoplasm and are ultimately released into the lumen. Defects in spermiogenesis and spermiation are manifested as low sperm number, abnormal sperm morphology and poor motility and are commonly observed during reproductive toxicant administration, as well as in genetically modified mouse models of male infertility. This chapter summarizes the major physiological processes and the most commonly observed defects in spermiogenesis and spermiation, to aid in the diagnosis of the potential mechanisms that could be perturbed by experimental manipulation such as reproductive toxicant administration.</p>","PeriodicalId":22074,"journal":{"name":"Spermatogenesis","volume":"4 2","pages":"e979623"},"PeriodicalIF":0.0,"publicationDate":"2015-01-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4161/21565562.2014.979623","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34109259","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2015-01-26eCollection Date: 2014-05-01DOI: 10.4161/21565562.2014.979110
Caitlin J Murphy, John H Richburg
After exposure to toxicants, degenerating germ cells represents the most common testicular histopathological alteration, regardless of the mechanism of toxicity. Therefore, deciphering the primary toxicant cellular target and mechanism of action can be extremely difficult. However, most testicular toxicants display a cell-specific and a stage-specific pattern of damage, which is the best evidence for identifying the primary cellular target (i.e. germ cell, Sertoli cell, peritubular myoid cell, or Leydig cell). Some toxicant-induced Sertoli cell injury presents with germ cell apoptosis occurring primarily in spermatocytes in rats in stages XI-XIV, I and II. Although some toxicants result in spermatid degeneration and apoptosis, it is still unclear if spermatid apoptosis is a result of Sertoli cell-selective apoptosis or a direct effect of toxicants on spermatids, therefore if this is seen as the earliest change, one cannot infer the mechanism of apoptosis. This review summarizes some of the distinguishing features of Sertoli cell-induced germ cell apoptosis and the associated mechanisms of cell death to provide the toxicologist observing similar cell death, with evidence about a potential mode of action.
{"title":"Implications of Sertoli cell induced germ cell apoptosis to testicular pathology.","authors":"Caitlin J Murphy, John H Richburg","doi":"10.4161/21565562.2014.979110","DOIUrl":"https://doi.org/10.4161/21565562.2014.979110","url":null,"abstract":"<p><p>After exposure to toxicants, degenerating germ cells represents the most common testicular histopathological alteration, regardless of the mechanism of toxicity. Therefore, deciphering the primary toxicant cellular target and mechanism of action can be extremely difficult. However, most testicular toxicants display a cell-specific and a stage-specific pattern of damage, which is the best evidence for identifying the primary cellular target (i.e. germ cell, Sertoli cell, peritubular myoid cell, or Leydig cell). Some toxicant-induced Sertoli cell injury presents with germ cell apoptosis occurring primarily in spermatocytes in rats in stages XI-XIV, I and II. Although some toxicants result in spermatid degeneration and apoptosis, it is still unclear if spermatid apoptosis is a result of Sertoli cell-selective apoptosis or a direct effect of toxicants on spermatids, therefore if this is seen as the earliest change, one cannot infer the mechanism of apoptosis. This review summarizes some of the distinguishing features of Sertoli cell-induced germ cell apoptosis and the associated mechanisms of cell death to provide the toxicologist observing similar cell death, with evidence about a potential mode of action.</p>","PeriodicalId":22074,"journal":{"name":"Spermatogenesis","volume":"4 2","pages":"e979110"},"PeriodicalIF":0.0,"publicationDate":"2015-01-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4161/21565562.2014.979110","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34109256","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2015-01-21eCollection Date: 2014-05-01DOI: 10.4161/21565562.2014.981485
C Yan Cheng
There are numerous types of junctions in the seminiferous epithelium which are integrated with, and critically dependent on the Sertoli cell cytoskeleton. These include the basal tight junctions between Sertoli cells that form the main component of the blood-testis barrier, the basal ectoplasmic specializations (basal ES) and basal tubulobulbar complexes (basal TBC) between Sertoli cells; as well as apical ES and apical TBC between Sertoli cells and the developing spermatids that orchestrate spermiogenesis and spermiation. These junctions, namely TJ, ES, and TBC interact with actin microfilament-based cytoskeleton, which together with the desmosomal junctions that interact with the intermediate filament-based cytoskeleton plus the highly polarized microtubule-based cytoskeleton are working in concert to move spermatocytes and spermatids between the basal and luminal aspect of the seminiferous epithelium. In short, these various junctions are structurally complexed with the actin- and microtubule-based cytoskeleton or intermediate filaments of the Sertoli cell. Studies have shown toxicants (e.g., cadmium, bisphenol A (BPA), perfluorooctanesulfonate (PFOS), phthalates, and glycerol), and some male contraceptives under development (e.g., adjudin, gamendazole), exert their effects, at least in part, by targeting cell junctions in the testis. The disruption of Sertoli-Sertoli cell and Sertoli-germ cell junctions, results in the loss of germ cells from the seminiferous epithelium. Adjudin, a potential male contraceptive under investigation in our laboratory, produces loss of spermatids from the seminiferous tubules through disruption of the Sertoli cell spermatid junctions and disruption of the Sertoli cell cytoskeleton. The molecular and structural changes associated with adjudin administration are described, to provide an example of the profile of changes caused by disturbance of Sertoli-germ cell and also Sertoli cell-cell junctions.
{"title":"Toxicants target cell junctions in the testis: Insights from the indazole-carboxylic acid model.","authors":"C Yan Cheng","doi":"10.4161/21565562.2014.981485","DOIUrl":"https://doi.org/10.4161/21565562.2014.981485","url":null,"abstract":"<p><p>There are numerous types of junctions in the seminiferous epithelium which are integrated with, and critically dependent on the Sertoli cell cytoskeleton. These include the basal tight junctions between Sertoli cells that form the main component of the blood-testis barrier, the basal ectoplasmic specializations (basal ES) and basal tubulobulbar complexes (basal TBC) between Sertoli cells; as well as apical ES and apical TBC between Sertoli cells and the developing spermatids that orchestrate spermiogenesis and spermiation. These junctions, namely TJ, ES, and TBC interact with actin microfilament-based cytoskeleton, which together with the desmosomal junctions that interact with the intermediate filament-based cytoskeleton plus the highly polarized microtubule-based cytoskeleton are working in concert to move spermatocytes and spermatids between the basal and luminal aspect of the seminiferous epithelium. In short, these various junctions are structurally complexed with the actin- and microtubule-based cytoskeleton or intermediate filaments of the Sertoli cell. Studies have shown toxicants (e.g., cadmium, bisphenol A (BPA), perfluorooctanesulfonate (PFOS), phthalates, and glycerol), and some male contraceptives under development (e.g., adjudin, gamendazole), exert their effects, at least in part, by targeting cell junctions in the testis. The disruption of Sertoli-Sertoli cell and Sertoli-germ cell junctions, results in the loss of germ cells from the seminiferous epithelium. Adjudin, a potential male contraceptive under investigation in our laboratory, produces loss of spermatids from the seminiferous tubules through disruption of the Sertoli cell spermatid junctions and disruption of the Sertoli cell cytoskeleton. The molecular and structural changes associated with adjudin administration are described, to provide an example of the profile of changes caused by disturbance of Sertoli-germ cell and also Sertoli cell-cell junctions.</p>","PeriodicalId":22074,"journal":{"name":"Spermatogenesis","volume":"4 2","pages":"e981485"},"PeriodicalIF":0.0,"publicationDate":"2015-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4161/21565562.2014.981485","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34109260","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2015-01-13eCollection Date: 2014-05-01DOI: 10.1080/21565562.2014.1005511
D M Creasy, R E Chapin
The toxicologic literature abounds with examples of drugs and environmental chemicals that cause changes in spermatogenesis and/or epididymal sperm in laboratory animals. Unless proven otherwise, the assumption must be made that similar changes are likely to occur in humans exposed to these chemicals. For those working in the pharmaceutical industry, this can mean the costly termination of a drug development program and the loss of a potentially valuable therapeutic molecule unless studies can be conducted to investigate potential mechanisms of toxicity and/or realistically predict human risk. For those working in regulatory environmental toxicity, mechanistic studies are rarely conducted but demonstration of a mode of action (MOA) can provide valuable information to allow a better understanding of the real threat of environmental toxicants versus the perceived threat. For both disciplines, it is essential to understand the basic science underlying spermatogenesis and sperm maturation in order to address any mechanistic approach to investigating a toxicologic lesion. The toxicologic pathologist is generally the person to first identify and sound the alarm regarding a male reproductive toxicant in a drug development or environmental chemical program. Organ weights and histopathology will be the main (often only) information that will be available from repeat dose studies. Given a good understanding of spermatogenesis and spermatogenic staging, the pathologist may be able to take a guess at the earliest cell type affected (Sertoli or germ cell), get a feel for the pathogenesis and recovery of the lesion over time, and they may even be able to assess whether endocrine disturbance is a major and primary event. Very soon after sounding the alarm, a lot of questions will be asked regarding the likely mechanism of toxicity, whether the spermatogenic disruption is “on or off target” for the therapeutic molecule, and is the toxicity, (which often affects one species and not the other) relevant to man? Such questions are extremely difficult to answer or even address when dealing with disturbances of spermatogenesis because of the complexity of the cellular interactions within the testis, the relative lack of knowledge of the physiology and molecular biology of spermatogenesis and the fact that we are often working with species (e.g. dog and monkey) for which there is remarkably little basic biologic information. In fact, many of these questions are never addressed by pharma companies with a reproductive issue, partly because of time and money constraints, but also because the main objective of repeat dose regulatory studies is risk assessment. So if any follow up mechanistic work is conducted, it is limited and only aimed at whether an effect is relevant to man or justifying why a higher dose can safely be used in clinical trials. This approach contrasts with basic research on cell physiology, endocrinology and molecular biology of spermatogenesis where in
{"title":"Testicular and epididymal toxicity: Pathogenesis and potential mechanisms of toxicity.","authors":"D M Creasy, R E Chapin","doi":"10.1080/21565562.2014.1005511","DOIUrl":"https://doi.org/10.1080/21565562.2014.1005511","url":null,"abstract":"The toxicologic literature abounds with examples of drugs and environmental chemicals that cause changes in spermatogenesis and/or epididymal sperm in laboratory animals. Unless proven otherwise, the assumption must be made that similar changes are likely to occur in humans exposed to these chemicals. For those working in the pharmaceutical industry, this can mean the costly termination of a drug development program and the loss of a potentially valuable therapeutic molecule unless studies can be conducted to investigate potential mechanisms of toxicity and/or realistically predict human risk. For those working in regulatory environmental toxicity, mechanistic studies are rarely conducted but demonstration of a mode of action (MOA) can provide valuable information to allow a better understanding of the real threat of environmental toxicants versus the perceived threat. For both disciplines, it is essential to understand the basic science underlying spermatogenesis and sperm maturation in order to address any mechanistic approach to investigating a toxicologic lesion. The toxicologic pathologist is generally the person to first identify and sound the alarm regarding a male reproductive toxicant in a drug development or environmental chemical program. Organ weights and histopathology will be the main (often only) information that will be available from repeat dose studies. Given a good understanding of spermatogenesis and spermatogenic staging, the pathologist may be able to take a guess at the earliest cell type affected (Sertoli or germ cell), get a feel for the pathogenesis and recovery of the lesion over time, and they may even be able to assess whether endocrine disturbance is a major and primary event. Very soon after sounding the alarm, a lot of questions will be asked regarding the likely mechanism of toxicity, whether the spermatogenic disruption is “on or off target” for the therapeutic molecule, and is the toxicity, (which often affects one species and not the other) relevant to man? Such questions are extremely difficult to answer or even address when dealing with disturbances of spermatogenesis because of the complexity of the cellular interactions within the testis, the relative lack of knowledge of the physiology and molecular biology of spermatogenesis and the fact that we are often working with species (e.g. dog and monkey) for which there is remarkably little basic biologic information. In fact, many of these questions are never addressed by pharma companies with a reproductive issue, partly because of time and money constraints, but also because the main objective of repeat dose regulatory studies is risk assessment. So if any follow up mechanistic work is conducted, it is limited and only aimed at whether an effect is relevant to man or justifying why a higher dose can safely be used in clinical trials. This approach contrasts with basic research on cell physiology, endocrinology and molecular biology of spermatogenesis where in","PeriodicalId":22074,"journal":{"name":"Spermatogenesis","volume":"4 2","pages":"e1005511"},"PeriodicalIF":0.0,"publicationDate":"2015-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/21565562.2014.1005511","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34109253","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2015-01-08eCollection Date: 2014-05-01DOI: 10.4161/21565562.2014.979114
Wilma De Grava Kempinas, Gary Robert Klinefelter
While most of this Special Issue is devoted to the testis (which is where most drug and chemically induced toxicity of the male reproductive tract is identified), being able to recognize and understand the potential effects of toxicants on the epididymis is immensely important and an area that is often overlooked. The epididymis is the organ where the post-testicular sperm differentiation occurs, through a complex and still not completely understood sperm maturation process, allowing them to fertilize the oocyte. Also in the epididymis, sperm are stored until ejaculation, while being protected from immunogenic reaction by a blood-epididymis barrier. From a toxicologic perspective the epididymis is inherently complicated as its structure and function can be altered both indirectly and directly. In this review we will discuss the factors that must be considered when attempting to distinguish between indirect and direct epididymal toxicity and highlight what is currently known about mechanisms of epididymal toxicants, using the rat as a reference model. We identify 2 distinguishable signature lesions - one representing androgen deprivation (secondary to Leydig cell toxicity in the testis) and another representing a direct acting toxicant. Other commonly observed alterations will also be shown and discussed. Finally, we point out that many of the key functions of the epididymis can be altered in the absence of a detectable change in tissue structure. Collectively, we hope this will provide pathologists with increased confidence in identification of epididymal toxicity and enable more informed guidance as mechanism of action is considered.
{"title":"Interpreting histopathology in the epididymis.","authors":"Wilma De Grava Kempinas, Gary Robert Klinefelter","doi":"10.4161/21565562.2014.979114","DOIUrl":"https://doi.org/10.4161/21565562.2014.979114","url":null,"abstract":"<p><p>While most of this Special Issue is devoted to the testis (which is where most drug and chemically induced toxicity of the male reproductive tract is identified), being able to recognize and understand the potential effects of toxicants on the epididymis is immensely important and an area that is often overlooked. The epididymis is the organ where the post-testicular sperm differentiation occurs, through a complex and still not completely understood sperm maturation process, allowing them to fertilize the oocyte. Also in the epididymis, sperm are stored until ejaculation, while being protected from immunogenic reaction by a blood-epididymis barrier. From a toxicologic perspective the epididymis is inherently complicated as its structure and function can be altered both indirectly and directly. In this review we will discuss the factors that must be considered when attempting to distinguish between indirect and direct epididymal toxicity and highlight what is currently known about mechanisms of epididymal toxicants, using the rat as a reference model. We identify 2 distinguishable signature lesions - one representing androgen deprivation (secondary to Leydig cell toxicity in the testis) and another representing a direct acting toxicant. Other commonly observed alterations will also be shown and discussed. Finally, we point out that many of the key functions of the epididymis can be altered in the absence of a detectable change in tissue structure. Collectively, we hope this will provide pathologists with increased confidence in identification of epididymal toxicity and enable more informed guidance as mechanism of action is considered.</p>","PeriodicalId":22074,"journal":{"name":"Spermatogenesis","volume":"4 2","pages":"e979114"},"PeriodicalIF":0.0,"publicationDate":"2015-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4161/21565562.2014.979114","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34109258","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2015-01-07eCollection Date: 2014-05-01DOI: 10.4161/21565562.2014.979653
David M Klein, Nathan J Cherrington
Transporters have a huge impact on the toxicology and pharmacological effects of xenobiotics in addition to being implicated in several diseases. While these important proteins have been well studied in organs such as the kidney or liver, characterization of transporters in the testis is still in the early stages. Knowledge of transporter function may greatly advance the field's understanding of the physiological and toxicological processes that occur in the testis. Several foundational studies involving both organic and inorganic transporters have been critical in furthering our understanding of how the testis interacts with endogenous and xenobiotic compounds. This review provides an overview of how transporters function, their clinical significance, and highlights what is known for many of the important transporters in the testis.
{"title":"Organic and inorganic transporters of the testis: A review.","authors":"David M Klein, Nathan J Cherrington","doi":"10.4161/21565562.2014.979653","DOIUrl":"10.4161/21565562.2014.979653","url":null,"abstract":"<p><p>Transporters have a huge impact on the toxicology and pharmacological effects of xenobiotics in addition to being implicated in several diseases. While these important proteins have been well studied in organs such as the kidney or liver, characterization of transporters in the testis is still in the early stages. Knowledge of transporter function may greatly advance the field's understanding of the physiological and toxicological processes that occur in the testis. Several foundational studies involving both organic and inorganic transporters have been critical in furthering our understanding of how the testis interacts with endogenous and xenobiotic compounds. This review provides an overview of how transporters function, their clinical significance, and highlights what is known for many of the important transporters in the testis.</p>","PeriodicalId":22074,"journal":{"name":"Spermatogenesis","volume":"4 2","pages":"e979653"},"PeriodicalIF":0.0,"publicationDate":"2015-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4581056/pdf/kspe-04-02-979653.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34039644","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2014-12-31eCollection Date: 2014-05-01DOI: 10.4161/21565562.2014.979103
Rex A Hess
Seminiferous tubular atrophy may involve indirectly the disruption of estrogen receptor-α (ESR1) function in efferent ductules of the testis. ESR1 helps to maintain fluid resorption by the ductal epithelium and the inhibition or stimulation of this activity in rodent species will lead to fluid accumulation in the lumen. If not resolved, the abnormal buildup of fluid in the head of the epididymis and efferent ductules becomes a serious problem for the testis, as it leads to an increase in testis weight, tubular dilation and seminiferous epithelial degeneration, as well as testicular atrophy. The same sequence of pathogenesis occurs if the efferent ductule lumen becomes occluded. This review provides an introduction to the role of estrogen in the male reproductive tract but focuses on the various overlapping mechanisms that could induce efferent ductule dysfunction and fluid backpressure histopathology. Although efferent ductules are difficult to find, their inclusion in routine histological evaluations is recommended, as morphological images of these delicate tubules may be essential for understanding the mechanism of testicular injury, especially if dilations are observed in the rete testis and/or seminiferous tubules. Signature Lesion: The rete testis and efferent ductules can appear dilated, as if the lumens were greatly expanded with excess fluid or the accumulation of sperm. Because the efferent ductules resorb most of the fluid arriving from the rete testis lumen, one of two mechanisms is likely to be involved: a) reduced fluid uptake, which has been caused by the disruption in estrogen receptor signaling or associated pathways; or b) an increased rate of fluid resorption, which results in luminal occlusion. Both mechanisms can lead to a temporary increase in testicular weight, tubular dilation and atrophy of the seminiferous tubules.
{"title":"Disruption of estrogen receptor signaling and similar pathways in the efferent ductules and initial segment of the epididymis.","authors":"Rex A Hess","doi":"10.4161/21565562.2014.979103","DOIUrl":"https://doi.org/10.4161/21565562.2014.979103","url":null,"abstract":"<p><p>Seminiferous tubular atrophy may involve indirectly the disruption of estrogen receptor-α (ESR1) function in efferent ductules of the testis. ESR1 helps to maintain fluid resorption by the ductal epithelium and the inhibition or stimulation of this activity in rodent species will lead to fluid accumulation in the lumen. If not resolved, the abnormal buildup of fluid in the head of the epididymis and efferent ductules becomes a serious problem for the testis, as it leads to an increase in testis weight, tubular dilation and seminiferous epithelial degeneration, as well as testicular atrophy. The same sequence of pathogenesis occurs if the efferent ductule lumen becomes occluded. This review provides an introduction to the role of estrogen in the male reproductive tract but focuses on the various overlapping mechanisms that could induce efferent ductule dysfunction and fluid backpressure histopathology. Although efferent ductules are difficult to find, their inclusion in routine histological evaluations is recommended, as morphological images of these delicate tubules may be essential for understanding the mechanism of testicular injury, especially if dilations are observed in the rete testis and/or seminiferous tubules. <b>Signature Lesion</b>: The rete testis and efferent ductules can appear dilated, as if the lumens were greatly expanded with excess fluid or the accumulation of sperm. Because the efferent ductules resorb most of the fluid arriving from the rete testis lumen, one of two mechanisms is likely to be involved: a) reduced fluid uptake, which has been caused by the disruption in estrogen receptor signaling or associated pathways; or b) an increased rate of fluid resorption, which results in luminal occlusion. Both mechanisms can lead to a temporary increase in testicular weight, tubular dilation and atrophy of the seminiferous tubules.</p>","PeriodicalId":22074,"journal":{"name":"Spermatogenesis","volume":"4 2","pages":"e979103"},"PeriodicalIF":0.0,"publicationDate":"2014-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4161/21565562.2014.979103","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34109252","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2014-12-31eCollection Date: 2015-01-01DOI: 10.4161/21565562.2014.979061
Duangporn Jamsai, Anne E O'Connor, Liza O'Donnell, Jennifer Chi Yi Lo, Moira K O'Bryan
Male germ cell genome integrity is critical for spermatogenesis, fertility and normal development of the offspring. Several DNA repair pathways exist in male germ cells. One such important pathway is the Fanconi anemia (FANC) pathway. Unlike in somatic cells, expression profiles and the role of the FANC pathway in germ cells remain largely unknown. In this study, we undertook an extensive expression analyses at both mRNA and protein levels of key components of the FANC pathway during spermatogenesis in the mouse. Herein we show that Fanc mRNAs and proteins displayed developmental enrichment within particular male germ cell types. Spermatogonia and pre-leptotene spermatocytes contained the majority of the FANC components examined i.e. complex I members FANCB, FANCG and FANCM, complex II members FANCD2 and FANCI, and complex III member FANCJ. Leptotene, zygotene and early pachytene spermatocytes contained FANCB, FANCG, FANCM and FANCD2. With the exception of FANCL, all FANC proteins examined were not detected in round spermatids. Elongating and elongated spermatids contained FANCB, FANCG, FANCL and FANCJ. qPCR analysis on isolated spermatocytes and round spermatids showed that Fancg, Fancl, Fancm, Fancd2, Fanci and Fancj mRNAs were expressed in both of these germ cell types, indicating that some degree of translational repression of these FANC proteins occurs during the transition from meiosis to spermiogenesis. Taken together, our findings raise the possibility that the assembly of FANC protein complexes in each of the male germ cell type is unique and may be distinct from the proposed model in mitotic cells.
{"title":"Uncoupling of transcription and translation of Fanconi anemia (FANC) complex proteins during spermatogenesis.","authors":"Duangporn Jamsai, Anne E O'Connor, Liza O'Donnell, Jennifer Chi Yi Lo, Moira K O'Bryan","doi":"10.4161/21565562.2014.979061","DOIUrl":"https://doi.org/10.4161/21565562.2014.979061","url":null,"abstract":"<p><p>Male germ cell genome integrity is critical for spermatogenesis, fertility and normal development of the offspring. Several DNA repair pathways exist in male germ cells. One such important pathway is the Fanconi anemia (FANC) pathway. Unlike in somatic cells, expression profiles and the role of the FANC pathway in germ cells remain largely unknown. In this study, we undertook an extensive expression analyses at both mRNA and protein levels of key components of the FANC pathway during spermatogenesis in the mouse. Herein we show that Fanc mRNAs and proteins displayed developmental enrichment within particular male germ cell types. Spermatogonia and pre-leptotene spermatocytes contained the majority of the FANC components examined i.e. complex I members FANCB, FANCG and FANCM, complex II members FANCD2 and FANCI, and complex III member FANCJ. Leptotene, zygotene and early pachytene spermatocytes contained FANCB, FANCG, FANCM and FANCD2. With the exception of FANCL, all FANC proteins examined were not detected in round spermatids. Elongating and elongated spermatids contained FANCB, FANCG, FANCL and FANCJ. qPCR analysis on isolated spermatocytes and round spermatids showed that Fancg, Fancl, Fancm, Fancd2, Fanci and Fancj mRNAs were expressed in both of these germ cell types, indicating that some degree of translational repression of these FANC proteins occurs during the transition from meiosis to spermiogenesis. Taken together, our findings raise the possibility that the assembly of FANC protein complexes in each of the male germ cell type is unique and may be distinct from the proposed model in mitotic cells.</p>","PeriodicalId":22074,"journal":{"name":"Spermatogenesis","volume":"5 1","pages":"e979061"},"PeriodicalIF":0.0,"publicationDate":"2014-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4161/21565562.2014.979061","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34041477","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2014-12-31eCollection Date: 2014-05-01DOI: 10.4161/21565562.2014.979619
Mary Gregory, Daniel G Cyr
The blood-epididymis barrier (BEB) is a critical structure for male fertility. It enables the development of a specific luminal environment that allows spermatozoa to acquire both the ability to swim and fertilize an ovum. The presence of tight junctions and specific cellular transporters can regulate the composition of the epididymal lumen to favor proper sperm maturation. The BEB is also at the interface between the immune system and sperm. Not only does the BEB protect maturing spermatozoa from the immune system, it is also influenced by cytokines released during inflammation, which can result in the loss of barrier function. Such a loss is associated with an immune response, decreased sperm functions, and appears to be a contributing factor to post-testicular male infertility. Alterations in the BEB may be responsible for the formation of inflammatory conditions such as sperm granulomas. The present review summarizes current knowledge on the morphological, physiological and pathological components associated with the BEB, the role of immune function on the regulation of the BEB, and how disturbance of these factors can result in inflammatory lesions of the epididymis.
{"title":"The blood-epididymis barrier and inflammation.","authors":"Mary Gregory, Daniel G Cyr","doi":"10.4161/21565562.2014.979619","DOIUrl":"https://doi.org/10.4161/21565562.2014.979619","url":null,"abstract":"<p><p>The blood-epididymis barrier (BEB) is a critical structure for male fertility. It enables the development of a specific luminal environment that allows spermatozoa to acquire both the ability to swim and fertilize an ovum. The presence of tight junctions and specific cellular transporters can regulate the composition of the epididymal lumen to favor proper sperm maturation. The BEB is also at the interface between the immune system and sperm. Not only does the BEB protect maturing spermatozoa from the immune system, it is also influenced by cytokines released during inflammation, which can result in the loss of barrier function. Such a loss is associated with an immune response, decreased sperm functions, and appears to be a contributing factor to post-testicular male infertility. Alterations in the BEB may be responsible for the formation of inflammatory conditions such as sperm granulomas. The present review summarizes current knowledge on the morphological, physiological and pathological components associated with the BEB, the role of immune function on the regulation of the BEB, and how disturbance of these factors can result in inflammatory lesions of the epididymis.</p>","PeriodicalId":22074,"journal":{"name":"Spermatogenesis","volume":"4 2","pages":"e979619"},"PeriodicalIF":0.0,"publicationDate":"2014-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4161/21565562.2014.979619","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34109254","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2014-12-31eCollection Date: 2014-09-01DOI: 10.4161/21565562.2014.982420
Dustin S Siegel, Sam Alvino, Stanley E Trauth, David M Sever, Kevin M Gribbins
Previous investigators have described the spermatogenic cycles of numerous species of plethodontid salamanders. Most studies describe a fairly stereotypical cycle with meiotic divisions of spermatogenesis commencing in the spring/summer. However, many studies lack details obtainable from histological examination and/or testicular squashes and, instead, provide only mensural data from the testes. Studies that lacked microscopic evaluation often revealed spermatogenic cycles that varied greatly from that of the stereotypical cycle with meiotic divisions commencing in the fall/winter. Those studies hamper comparisons between the spermatogenic cycles of different species and their environments, as they do not provide a correlation between testicular size and any aspect of the spermatogenic cycle. In the following manuscript, we elucidate the spermatogenic cycle of Eurycea longicauda longicauda in an effort to outline an appropriate protocol for analyzing spermatogenesis in salamanders that will facilitate future comparative studies. Like many Nearctic plethodontids, E. l. longicauda exhibits a meiotic wave that travels through the testes during the summer; this process is followed by spermiogenesis, spermiation, and recrudescence in the fall, winter, and spring.
{"title":"Spermatogenic cycle of a plethodontid salamander, <i>Eurycea longicauda</i> (Amphibia, Urodela).","authors":"Dustin S Siegel, Sam Alvino, Stanley E Trauth, David M Sever, Kevin M Gribbins","doi":"10.4161/21565562.2014.982420","DOIUrl":"10.4161/21565562.2014.982420","url":null,"abstract":"<p><p>Previous investigators have described the spermatogenic cycles of numerous species of plethodontid salamanders. Most studies describe a fairly stereotypical cycle with meiotic divisions of spermatogenesis commencing in the spring/summer. However, many studies lack details obtainable from histological examination and/or testicular squashes and, instead, provide only mensural data from the testes. Studies that lacked microscopic evaluation often revealed spermatogenic cycles that varied greatly from that of the stereotypical cycle with meiotic divisions commencing in the fall/winter. Those studies hamper comparisons between the spermatogenic cycles of different species and their environments, as they do not provide a correlation between testicular size and any aspect of the spermatogenic cycle. In the following manuscript, we elucidate the spermatogenic cycle of <i>Eurycea longicauda longicauda</i> in an effort to outline an appropriate protocol for analyzing spermatogenesis in salamanders that will facilitate future comparative studies. Like many Nearctic plethodontids, <i>E. l. longicauda</i> exhibits a meiotic wave that travels through the testes during the summer; this process is followed by spermiogenesis, spermiation, and recrudescence in the fall, winter, and spring.</p>","PeriodicalId":22074,"journal":{"name":"Spermatogenesis","volume":"4 3","pages":"e982420"},"PeriodicalIF":0.0,"publicationDate":"2014-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4581059/pdf/kspe-04-03-982420.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34039651","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}